Saturday, June 13, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 199 of 1,261

  1. US 11633498

    Muscle targeting complexes and uses thereof for treating myotonic dystrophy

    Dyne Therapeutics, Inc. · Granted Apr 25, 2023 · Expires Apr 20, 2043

    granted

  2. US 11634463

    Methods and compositions for treating hemophilia

    Sangamo Therapeutics, Inc. · Granted Apr 25, 2023 · Expires Apr 20, 2043

    granted

  3. US 11634418

    Amino acid compounds and methods of use

    Pliant Therapeutics, Inc. · Granted Apr 25, 2023 · Expires Apr 20, 2043

    granted

  4. US 11633377

    Treatment of circadian rhythm disorders

    VANDA PHARMACEUTICALS INC. · Granted Apr 25, 2023 · Expires Apr 20, 2043

    granted

  5. US 11633361

    Soft chew pharmaceutical formulations

    First Time US Generics LLC · Granted Apr 25, 2023 · Expires Apr 20, 2043

    granted

  6. US 11629167

    Betulastatin compounds

    ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Apr 18, 2023 · Expires Apr 13, 2043

    granted

  7. US 11629348

    Linkage modified oligomeric compounds and uses thereof

    Ionis Pharmaceuticals, Inc. · Granted Apr 18, 2023 · Expires Apr 13, 2043

    granted

  8. US 11628229

    Method of synthesizing 18F radiolabeled biomolecular agents

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Apr 18, 2023 · Expires Apr 13, 2043

    granted

  9. US 11629195

    Anti-IL2 receptor gamma antigen-binding proteins

    REGENERON PHARMACEUTICALS, INC. · Granted Apr 18, 2023 · Expires Apr 13, 2043

    granted

  10. US 11629372

    Random heteropolymers preserve protein function in foreign environments

    The Regents of the University of California · Granted Apr 18, 2023 · Expires Apr 13, 2043

    granted

  11. US 11629060

    Purification of clinoptilolite

    Revelation Health LLC · Granted Apr 18, 2023 · Expires Apr 13, 2043

    granted

  12. US 11629159

    Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use

    Compass Pathfinder Limited · Granted Apr 18, 2023 · Expires Apr 13, 2043

    granted

  13. US 11629349

    RNAi agents for inhibiting expression of xanthine dehydrogenase (XDH), pharmaceutical compositions thereof, and methods of use

    Arrowhead Pharmaceuticals, Inc. · Granted Apr 18, 2023 · Expires Apr 13, 2043

    granted

  14. US 11631483

    Systems and methods for coordinating manufacturing of cells for patient-specific immunotherapy

    Iovance Biotherapeutics, Inc. · Granted Apr 18, 2023 · Expires Apr 13, 2043

    granted

  15. US 11628205

    Conjugates of a factor VIII moiety having an oxime-containing linkage

    Nektar Therapeutics · Granted Apr 18, 2023 · Expires Apr 13, 2043

    granted

  16. US 11628173

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Apr 18, 2023 · Expires Apr 13, 2043

    granted

  17. US 11629146

    Substituted [1,2,4]triazolo[4,3-a]pyrazines as modulators of sodium channel activity

    PRAXIS PRECISION MEDICINES, INC. · Granted Apr 18, 2023 · Expires Apr 13, 2043

    granted

  18. US 11629122

    Linkers for antibody drug conjugates

    The Board of Regents of the University of Texas System · Granted Apr 18, 2023 · Expires Apr 13, 2043

    granted

  19. US 11629174

    Cryptic metabolites and method for activating silent biosynthetic gene clusters in actinomycete bacteria

    THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Apr 18, 2023 · Expires Apr 13, 2043

    granted

  20. US 11629334

    Methods of isolating T cells and T cell receptors having antigenic specificity for a cancer-specific mutation from peripheral blood

    THE UNITED STATES OF AMERICA, represented by the Secretary, Department of Health and Human Services · Granted Apr 18, 2023 · Expires Apr 13, 2043

    granted

  21. US 11629145

    SHP2 phosphatase inhibitors and methods of use thereof

    Relay Therapeutics, Inc. · Granted Apr 18, 2023 · Expires Apr 13, 2043

    granted

  22. US 11628146

    Estrogen receptor ligand treatment for neurodegenerative diseases

    The Regents of the University of California · Granted Apr 18, 2023 · Expires Apr 13, 2043

    granted

  23. US 11628010

    Selective fat removal using photothermal heating

    The Regents of the University of California · Granted Apr 18, 2023 · Expires Apr 13, 2043

    granted

  24. US 11628215

    HIV vaccines comprising one or more population episensus antigens

    Vir Biotechnology, Inc. · Granted Apr 18, 2023 · Expires Apr 13, 2043

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.